Research and Markets: Cordis Medical Device Company May Be Expanding at the Beginning of 2007 Through J&J's Planned Acquisition of Conor Medsystems for Approximately US$1.4 Billion.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c47899) has announced the addition of Cordis Medical Device Company Intelligence Report from Espicom Business Intelligence Introduction Espicom Business Intelligence is a publisher of independent and impartial information and analysis services focusing on the pharmaceutical and medical device markets. to their offering. Based in Miami Lakes, Florida Miami Lakes is an incorporated town and former census-designated place in Miami-Dade County, Florida, United States. The population was 22,676 at the 2000 census. As of 2004, the population recorded by the U.S. Census Bureau is 22,688. , USA, Johnson & Johnson's Cordis unit manufactures and markets products for interventional medicine, minimally-invasive computer-based imaging and electrophysiology (EP). The company's products are marketed through four divisions: Cordis Cardiology for coronary applications, Cordis Endovascular for vascular disease, Biosense Webster for EP in cardiovascular procedures and Cordis Neurovascular which leverages the company's technology into applications for the brain, as follows:- Cordis Cardiology, based at the Cordis headquarters in Miami Lakes, is the company's largest business and manufactures diagnostic, interventional products and stents. Cordis Cardiology claims to have created the diagnostic market and introduced nylon balloon technology. Cordis Neurovascular was formed in 1993 in order to leverage technologies used in cardiology and peripheral systems into the brain. In 1994, the division claimed to have introduced the first neurointerventional microcatheter which utilised braided technology and expanded the treatment opportunities for cerebrovascular disease. Cordis Endovascular, based in Warren, New Jersey, USA, manufactures interventional and diagnostic medical products, including nitinol and stainless steel stents, Carotid stenting products, vena cava filters, balloon catheters and accessories. The company serves the cardiology, radiology and vascular surgery communities with technologies for the treatment of peripheral vascular disease Peripheral Vascular Disease Definition Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms. . Biosense Webster, based in Diamond Bar, California Diamond Bar is a city in Los Angeles County, California, United States. The population was 56,287 at the 2000 census. It is named after the "diamond over a bar" branding iron registered in 1918 by ranch owner Frederick E. Lewis. , USA, is a leader in intracardiac intracardiac /in·tra·car·di·ac/ (-kahr´de-ak) within the heart. in·tra·car·di·ac adj. Within the heart. intracardiac within the heart. EP and interventional cardiology, having pioneered the development of 3D cardiac mapping and navigation for disease evaluation and therapy. The business was formed in 1999 when two units were combined and in 1993 Cordis acquired EP company, Webster Laboratories. In 1997, following Cordis' acquisition by J&J, Cordis merged with Israeli company, Biosense, combining Biosense's navigation technology with Webster's EP mapping and arrhythmia arrhythmia (ārĭth`mēə), disturbance in the rate or rhythm of the heartbeat. Various arrhythmias can be symptoms of serious heart disorders; however, they are usually of no medical significance except in the presence of treatments. The company may also be expanded at the beginning of 2007 through J&J's planned acquisition of Conor Medsystems for approximately US$1.4 billion. Conor will operate as part of Cordis and provide the company with controlled drug delivery technology, currently employed on Conor's CoStar paclitaxel-eluting cobalt chromium stent which has a bioabsorbable polymer. CoStar is sold outside the US through Biotronik and enrolment in a US pivotal clinical trial has been completed. Currently, Cordis operates US sites in Warren and Raritan, New Jersey
Raritan is a Borough in Somerset County, New Jersey, United States. As of the United States 2000 Census, the borough population was 6,338. , for endovascular products and in Miami Lakes, Florida, for cardiology and neurovascular products. Its Nitinol Devices and Components and LuMend units are based in California. Internationally, Cordis has operations in Mexico, Puerto Rico, the Netherlands, Belgium, Italy, Germany and France. It is also building a facility in Cashel, Ireland, and an R&D centre in Silicon Valley, California, USA. Biosense Webster has US manufacturing sites in Baldwin Park and Irwindale, California, and international operations in Israel and Mexico. In April and July 2004, Cordis received FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. Warning Letters following post-approval site inspections at its facilities in Miami Lakes, Florida, and Warren, New Jersey, USA; San German, Puerto Rico; Roden, the Netherlands; Beerse, Belgium; and Latina, Italy, including sites involved in the production of the Cypher See cipher. sirolimus-eluting stent and Precise Nitinol biliary stent. Cordis hopes to have the Warning Letters removed by the end of 2006. Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. . Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available. Content Outline: Executive Summary Overview Strategic Focus Product Portfolio And R&D Cardiology Endovascular Products Neurovascular Disease Management Biosense Webster Products Research And Development International Activities The Americas Middle East Europe Appendices Appendix 1 - Key Corporate Events Appendix 2 - Mergers And Acquisitions Appendix 3 - Divestitures Appendix 4 - Agreements Appendix 5 - Litigation Index of Tables Index of Charts Companies Mentioned: - Brivant - ClearStream Technologies - Siemens Medical Solutions Siemens Medical Solutions (Siemens Med) is a supplier to the healthcare industry, and is headquartered in Erlangen, Germany. Its U.S. division, Siemens Medical Solutions USA, Inc., is a Delaware corporation, with headquarters in Malvern, Pennsylvania. - Research Foundation of SUNY SUNY - State University of New York - GE Healthcare - Pemstar - Stereotaxis stereotaxis /ster·eo·tax·is/ (-tak´sis) 1. stereotactic surgery. 2. thigmotaxis. ster·e·o·tax·is or ster·e·o·tax·y n. 1. - BMC (BMC Software, Inc., Houston, TX, www.bmc.com) A leading supplier of software that supports and improves the availability, performance, and recovery of applications in complex computing environments. Industries - Stockert GmbH - Wyeth Pharmaceuticals - SurModics For more information visit http://www.researchandmarkets.com/reports/c47899 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion